Table 5.
Comparison with other studies that use multimodal data.
Study | Method | Data source | Brain region | Objective | Performance |
---|---|---|---|---|---|
This study | 3D-CNN multimodal | Baseline MRI + | Whole brain | Predicting fast decliners | AUC: 0.70 |
Baseline MMSE + | Acc: 63.3% | ||||
Demographic data + | Sens: 60.8% | ||||
Baseline scalar volume | Spec: 65.2% | ||||
Lee et al.4 | Recurrent NN multimodal | Baseline MRI + | Regional hippocampus | MCI-to-AD conversion | AUC: 0.86 |
Demographic data + | Acc: 81% | ||||
Long. CSF biomarkers + | Sens: 84% | ||||
Long. cognitive performance + | Spec: 80% | ||||
Lin et al.28 | 2.5D-CNN multimodal PCA + Lasso + NN | Baseline MRI + | Regional hippocampus | MCI-to-AD conversion | AUC: 0.86 |
325 free surfer feature | Acc: 79.9% | ||||
Sens:84.0% | |||||
Spec:74.8% | |||||
Lu et al.37 | Multimodal multiscale NN | MRI + FDG-PET | Whole brain | Stable MCI versus progressive MCI | Acc: 82.9% |
Long. time-points | Sens:79.7% | ||||
Spec:83.8% | |||||
Esmaeilzadeh et al.14 | Multimodal | MRI + | Whole brain | AD-NC-MCI classification | Acc: 94.1% |
Age + Gender | Sens:94% | ||||
Sens:91% | |||||
Moradi et al.8 | Random forest multimodal | Baseline MRI + Age | Whole brain | MCI-to-AD conversion | AUC: 0.9 |
Baseline cognitive measurements + | Acc: 82% | ||||
(RAVLT + ADAS-cog) | Sens: 87% | ||||
(MMSE + CRD-SB + FAQ) | Spec:74% | ||||
Spasov et al.35 | 3D-CNN multimodal | MRI + | Whole brain | MCI-to-AD conversion | AUC: 0.925 |
Demographic data + | Acc: 86% | ||||
Neuropsychological data + | Sens: 87.5% | ||||
APOe4 genetic data | Spec:85% |
ML, machine learning; 2-D: two-dimension, 3-D: three-dimension; NN, neural network; CNN, convolutional neural network; R-CNN, recurrent convolutional neural network; Acc, accuracy; Sens, sensitivity; Spec, specificity; AUC, area under curve; CSF, cerebrospinal fluid; Long, longitudinal; RAVLT, Rey’s auditory verbal learning test; ADAS-cog, Alzheimer’s disease assessment scale cognitive subtest; MMSE, mini-mental state examination; CDR-SB, clinical dementia rating sum of boxes; FAQ, functional activities questionnaire.